esmo group has launched its latest product—the Apollo Quad Handler. Designed to bridge the gap between the engineering and ...

由安徽医科大学第一附属医院、蚌埠医学院第一附属医院、安徽省公共卫生临床中心、泰莱生物合著的学术成果《血浆游离 5-羟甲基胞嘧啶：高潜力的胃肠癌症无创检测生物标志物》被 ESMO ASIA 收录，刊载于 Annals of Oncology 中 ...

The largest ever clinical trial of T cell therapy (a type of cell-based immunotherapy) for solid tumours has been completed. Led by a Singapore clinician-investigator, the global, international, ...

Now, new data from the POD1UM-303 study reported at ESMO suggests the company could resurrect the SCAC indication and move Zynyz into the first-line setting to boot. Given in combination with ...

esmo group (esmo) announced the launch of its latest product—the Apollo Quad Handler. Designed to bridge the gap between the ...

NIAGARA received a warm reception when it was presented at the ESMO cancer congress, with discussant Petros Grivas from the University of Washington and Fred Hutchinson Cancer Center in Seattle ...

The novel drug SHR-A1921 was safe and efficacious in patients with platinum-resistant ovarian cancer, according to phase 1 data.

格隆汇11月6日丨和黄医药(00013.HK)今日宣布索乐匹尼布 ...

【财华社讯】和黄医药(00013.HK)公布，索乐匹尼布(sovleplenib)的ESLIM-01III期研究以及和黄医药自主研发的化合物的数项研究的最新及更新后的数据将于2024年12月7日至10日在美国圣地亚哥召开的2024年美国血液学会(AS ...

HONG KONG, SHANGHAI, and FLORHAM PARK, N.J., Nov. 05, 2024 (GLOBE NEWSWIRE) -- (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from the sovleplenib ESLIM-01 Phase III ...

The largest ever clinical trial of T cell therapy for solid tumours has ended, heralding a new era for precision T cell ...

(UroToday.com) The 2024 European Society for Medical Oncology (ESMO) Annual Congress held in Barcelona, Spain between September 13 th and 16 th, 2024 was host to a session focusing on rare ...